Aligos Therapeutics, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 02/14/2025 | 325,000 | $12.95 M | 48.53% | 5.19% |
| ECOR1 CAPITAL, LLC | 02/14/2025 | 255,573 | $10.18 M | 0.00% | 4.08% |
| DEEP TRACK CAPITAL, LP | 02/14/2025 | 244,110 | $9.73 M | 0.00% | 3.90% |
| VIVO CAPITAL, LLC | 02/13/2025 | 141,879 | $5.65 M | 0.00% | 2.26% |
| VANGUARD GROUP INC | 02/11/2025 | 96,762 | $3.85 M | 51.63% | 1.54% |
| BAKER BROS. ADVISORS LP | 02/14/2025 | 83,055 | $3.31 M | 0.00% | 1.33% |
| HHLR ADVISORS, LTD. | 02/14/2025 | 76,247 | $3.04 M | 0.00% | 1.22% |
| TREXQUANT INVESTMENT LP | 02/12/2025 | 69,050 | $2.75 M | 100.00% | 1.10% |
| IKARIAN CAPITAL, LLC | 02/14/2025 | 64,300 | $2.56 M | 100.00% | 1.03% |
| UBS OCONNOR LLC | 02/14/2025 | 40,096 | $1.60 M | -40.24% | 0.64% |
| AVANTAX ADVISORY SERVICES, INC. | 02/10/2025 | 30,570 | $1.22 M | 100.00% | 0.49% |
| GEODE CAPITAL MANAGEMENT, LLC | 02/12/2025 | 27,253 | $1.09 M | 13.29% | 0.44% |
| DRIVE WEALTH MANAGEMENT, LLC | 01/22/2025 | 23,000 | $916,320 | 100.00% | 0.37% |
| BOOTHBAY FUND MANAGEMENT, LLC | 02/14/2025 | 18,543 | $738,753 | 100.00% | 0.30% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 02/06/2025 | 14,286 | $569,154 | 19.25% | 0.23% |
| BLACKROCK, INC. | 02/07/2025 | 13,721 | $546,645 | 51.33% | 0.22% |
| RENAISSANCE TECHNOLOGIES LLC | 02/13/2025 | 11,443 | $455,889 | -14.88% | 0.18% |
| STATE STREET CORP | 02/14/2025 | 9,582 | $381,747 | 100.00% | 0.15% |
| GOLDEN STATE WEALTH MANAGEMENT, LLC | 01/28/2025 | 2,674 | $106,532 | 100.00% | 0.04% |
| ALPHAMARK ADVISORS, LLC | 01/21/2025 | 1,100 | $44,000 | 1,000.00% | 0.02% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 02/13/2025 | 652 | $25,976 | 2,073.33% | 0.01% |
| BANK OF AMERICA CORP /DE/ | 02/14/2025 | 285 | $11,355 | -95.84% | 0.00% |
| SPIRE WEALTH MANAGEMENT | 01/24/2025 | 200 | $7,968 | 100.00% | 0.00% |
| 02/06/2025 | 171 | $6,813 | 100.00% | 0.00% | |
| NELSON, VAN DENBURG & CAMPBELL WEALTH MANAGEMENT GROUP, LLC | 01/17/2025 | 80 | $3,187 | 100.00% | 0.00% |
| ZRC WEALTH MANAGEMENT, LLC | 01/29/2025 | 4 | $160 | 0.00% | 0.00% |
| ACADIAN ASSET MANAGEMENT LLC | 02/11/2025 | 0 | $0 | -100.00% | 0.00% |
| ARMISTICE CAPITAL, LLC | 02/14/2025 | 0 | $0 | -100.00% | 0.00% |
| QUBE RESEARCH & TECHNOLOGIES LTD | 02/14/2025 | 0 | $0 | -100.00% | 0.00% |
| WOODLINE PARTNERS LP | 02/14/2025 | 0 | $0 | -100.00% | 0.00% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 02/14/2025 | 0 | $0 | -100.00% | 0.00% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Aligos Therapeutics, Inc. institutional Ownership - FAQ's
During the previous two years, 33 institutional investors and hedge funds held shares of Aligos Therapeutics, Inc.. The most heavily invested institutionals were:
Nelson, Van Denburg & Campbell Wealth Management Group, LLC: 0
Spire Wealth Management: 0
ADAGE CAPITAL PARTNERS GP, L.L.C.: 325,000
EcoR1 Capital, LLC: 255,573
Deep Track Capital, LP: 244,110
Vivo Capital, LLC: 141,879
25.81% of Aligos Therapeutics, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 4.82 M shares in the last 24 months. This purchase volume represents approximately $28.07 M in transactions.